Suppr超能文献

罗库溴铵 0.3 或 0.9mg/kg 用于 80 岁及以上患者时起效时间、作用持续时间和插管条件的比较:一项随机研究。

Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study.

机构信息

Department of Anaesthesia, Centre of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Department of Anaesthesia, Juliane Marie Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

出版信息

Acta Anaesthesiol Scand. 2022 Aug;66(7):811-817. doi: 10.1111/aas.14097. Epub 2022 Jun 27.

Abstract

BACKGROUND

Limited data exist about the optimal dose of rocuronium for intubation in elderly patients. We hypothesized that rocuronium 0.9 mg/kg would lead to a shorter onset time than 0.3 mg/kg in patients above 80 years.

METHODS

Thirty-four patients were randomized to either rocuronium 0.3 or 0.9 mg/kg. The primary outcome was onset time defined as time to train-of-four (TOF) count of 0. Other outcomes included duration of action (time to TOF ratio >0.9), proportion of excellent intubating conditions using the Fuchs-Buder scale and tracheal intubating conditions using the Intubating Difficulty Scale (IDS).

RESULTS

Rocuronium 0.9 mg/kg resulted in shorter onset time compared to rocuronium 0.3 mg/kg; 108 s (SD 40) vs. 228 s (SD 140) (difference: 119 s [95% CI: 41-196], p = .005), respectively. However, in 66% of the patients receiving rocuronium 0.3 mg/kg a TOF count of 0 was not obtained. Duration of action was longer after rocuronium 0.9 mg/kg: 118 min (SD 43) vs. 46 min (SD 13) (difference: 72 min [95% CI: 49-95] p < .0001), and a greater proportion of excellent intubating conditions (Fuchs-Buder) was obtained; 11/16 (69%) vs 4/18 (22%) (p = .006). No difference was found regarding IDS score.

CONCLUSION

Rocuronium 0.9 mg/kg resulted in a shorter onset time compared to rocuronium 0.3 mg/kg in patients above 80 years of age. In 66% of the patients receiving rocuronium 0.3 mg/kg a TOF count of 0 was not obtained.

摘要

背景

关于老年患者插管时罗库溴铵的最佳剂量,数据有限。我们假设罗库溴铵 0.9mg/kg 会比 0.3mg/kg 起效更快。

方法

34 名患者随机分为罗库溴铵 0.3 或 0.9mg/kg 组。主要结局是起效时间,定义为肌颤搐计数(TOF)达到 0 的时间。其他结局包括作用持续时间(TOF 比值>0.9 的时间)、Fuchs-Buder 插管条件评分和 Intubating Difficulty Scale(IDS)的气管插管条件评分。

结果

与罗库溴铵 0.3mg/kg 相比,罗库溴铵 0.9mg/kg 起效更快;108s(SD 40)vs. 228s(SD 140)(差异:119s [95% CI:41-196],p=0.005)。然而,66%的患者接受罗库溴铵 0.3mg/kg 后未能达到 TOF 计数为 0。罗库溴铵 0.9mg/kg 后作用持续时间更长:118min(SD 43)vs. 46min(SD 13)(差异:72min [95% CI:49-95],p<0.0001),且获得更好的插管条件(Fuchs-Buder)的比例更高;11/16(69%)vs 4/18(22%)(p=0.006)。IDS 评分无差异。

结论

与罗库溴铵 0.3mg/kg 相比,80 岁以上患者接受罗库溴铵 0.9mg/kg 起效更快。66%的患者接受罗库溴铵 0.3mg/kg 后未能达到 TOF 计数为 0。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b76/9544287/48e91b8fad01/AAS-66-811-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验